News

Interventions can ease insomnia in cancer patients


 

Sleeping woman

Credit: RelaxingMusic

A new study suggests cancer patients struggling with insomnia can choose between 2 behavioral interventions to obtain relief: cognitive behavioral therapy for insomnia (CBT-I) and mindfulness-based stress reduction (MBSR).

CBT-I is the gold standard of care, but the research showed that MBSR can also help improve sleep for cancer patients.

CBT-I involves stimulus control, sleep restriction, cognitive therapy, and relaxation training. When combined, these strategies target and reduce sleep-related physiologic and cognitive arousal to re-establish restorative sleep.

MBSR provides patients with psychoeducation on the relationship between stress and health. It also employs meditation techniques and gentle yoga to support mindful awareness and help patients respond better to stress.

Previous research has shown that MBSR can reduce distress and improve psychological well-being in patients with cancer. But this is the first study to directly compare MBSR to CBT-I in cancer patients.

The results are published in the Journal of Clinical Oncology.

“Insomnia and disturbed sleep are significant problems that can affect approximately half of all cancer patients,” said lead study author Sheila Garland, PhD, of Abramson Cancer Center at the University of Pennsylvania in Philadelphia.

“If not properly addressed, sleep disturbances can negatively influence therapeutic and supportive care measures for these patients, so it’s critical that clinicians can offer patients reliable, effective, and tailored interventions.”

With this in mind, Dr Garland and her colleagues tested behavioral interventions for insomnia in 111 patients recruited from a cancer center in Calgary, Alberta, Canada. Patients were randomized to either a CBT-I program (n=47) or an MBSR program (n=64) for 8 weeks.

Thirty-two patients completed the CBT-I program, and 40 completed the MBSR program. The researchers assessed patients immediately after program completion (at 2 months) and at 5 months from baseline.

Immediately after completion, MBSR was less effective than CBT-I at improving insomnia severity (P=0.35). But at the 5-month follow-up point, MBSR proved noninferior to CBT-I (P=0.02).

Patients in the CBT-I group showed greater overall improvement in subjectively measured sleep onset latency, sleep efficiency, sleep quality, and dysfunctional sleep beliefs than patients in the MBSR group.

But both groups showed progressive improvement over time when it came to subjectively measured total sleep time, wake after sleep onset, stress, and mood disturbance.

“That MBSR can produce similar improvements to CBT-I and that both [interventions] can effectively reduce stress and mood disturbance expands the available treatment options for insomnia in cancer patients,” Dr Garland said.

“This study suggests that we should not apply a ‘one-size-fits-all model’ to the treatment of insomnia and emphasizes the need to individualize treatment based on patient characteristics and preferences.”

Recommended Reading

CAR-T cells drive ALL into remission
MDedge Hematology and Oncology
Anticoagulation reaped survival benefit in leukemia patients with DVT
MDedge Hematology and Oncology
Survey: Internists lack tools to care for survivors of childhood cancer
MDedge Hematology and Oncology
Antipsychotic drug is active against T-ALL
MDedge Hematology and Oncology
Deaths from leukemia, NHL declining in the UK
MDedge Hematology and Oncology
AML scoring system could optimize treatment
MDedge Hematology and Oncology
Leukemia is leading cause of cancer death among young Americans
MDedge Hematology and Oncology
Out-of-pocket costs hinder adherence to imatinib
MDedge Hematology and Oncology
Internists may be ill-equipped to care for childhood cancer survivors
MDedge Hematology and Oncology
Ponatinib may be returning to market with new safety measures
MDedge Hematology and Oncology